BioSpace News Archive

Eli Lilly and Company announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network Trials Unit Study showed that solanezumab did not meet the primary endpoint.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, will present at the CECP 2020 CEO Investor Forum at Convene in New York, NY on Monday, February 24, 2020, at 3:05 pm ET.

Feb. 10, 2020 13:00 UTC LUNGguard safeguards lungs between donor and recipient patients CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Paragonix Technologies, Inc. today announced clearance of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Donor Lung Preservation System - LUNGguard 1,2 . The Paragonix LUNGguard Donor Lung Preservation System is intended to be used for the static hypothermic preservation of lungs during transportat

Awards for achievement in the contact lens field were presented recently to three team members of Innovega, a company engaged in developing stylish, lightweight, wearable display technology with a panoramic field of view for virtual and augmented reality

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at Noble Capital Markets’ 16th Annual Investor Conference on Monday, February 17, 2020 at 4:00 PM ET . The c

Presenting sponsor Eisai Inc. and METAvivor announce today that they have joined forces with AnaOno Intimates and #Cancerland to fearlessly unite the breast cancer community and shine a spotlight on metastatic breast cancer (MBC) while highlighting the #ThisIsMBC Beneath the Breast campaign through fashion, during New York Fashion Week.

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 24, 2020, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:40 a.m. ET.

Feb. 10, 2020 13:30 UTC OncoSec Announces Closing of the CGP/Sirtex Transaction Transaction Provides Immediate Cash Infusion of $30M at Premium to Market Price of $2.50/share SAN DIEGO & PENNINGTON, N.J.--( BUSINESS WIRE )-- OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, following shareholder approval, the proposed strategic investment by and partnersh

Gento (formerly Nursing Without Walls) a startup that provides on-demand staffing and care delivery management to home health agencies and skilled nursing facilities through their platform and mobile app, announces today a $5M Series A funding by Jeff Anderson at Palisades Growth Capital

EDMONTON, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro, will present at NobleCon16 - Noble Capital Markets’ 16th Annual Investor Conference on Monday, February 17, 2020 at 3:30 p.m. ET in Holly